The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 05, 2023

Filed:

Dec. 16, 2020
Applicant:

Insulet Corporation, Acton, MA (US);

Inventors:

Joon Bok Lee, Acton, MA (US);

Jason O'Connor, Acton, MA (US);

Yibin Zheng, Hartland, WI (US);

Assignee:

INSULET CORPORATION, Acton, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 5/172 (2006.01); A61M 5/142 (2006.01);
U.S. Cl.
CPC ...
A61M 5/1723 (2013.01); A61M 5/14244 (2013.01); A61M 2005/14208 (2013.01); A61M 2205/3303 (2013.01); A61M 2205/3569 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2230/201 (2013.01);
Abstract

Disclosed are a device, system, methods and computer-readable medium products that provide techniques to implement functionality to receive blood glucose measurements over a period of time. An average of missing blood glucose measurement values may be maintained over a predetermined time period. A count of a number of missing blood glucose measurement values over a period of time may be established. A controller may calculate a divergence of the number of missing blood glucose measurement values over the period of time from the average of missing blood glucose measurements over the predetermined time period. Based on a value of the divergence, a determination that a safety constraint for delivery of insulin is to be reduced. The safety constraint may be reduced by a predetermined percentage. An instruction to deliver an insulin dosage may be generated according to the reduced safety constraint may be forwarded to a wearable drug delivery device.


Find Patent Forward Citations

Loading…